Gerald L. Ray & Associates’s Medtronic MDT Stock Holding History

Gerald L. Ray & Associates’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$256K	Sell	3,298 -191	-5%	-$15.9K	0.03%	293
2017 Q2	$310K	Sell	3,489 -5,286	-60%	-$446K	0.04%	268
2017 Q1	$707K	Buy	8,775 +3,886	+79%	+$304K	0.1%	180
2016 Q4	$348K	Sell	4,889 -3,897	-44%	-$306K	0.05%	244
2016 Q3	$759K	Hold	8,786	–	–	0.11%	162
2016 Q2	$762K	Hold	8,786	–	–	0.12%	152
2016 Q1	$659K	Sell	8,786 -914	-9%	-$68.8K	0.11%	163
2015 Q4	$746K	Sell	9,700 -483	-5%	-$36.4K	0.12%	154
2015 Q3	$682K	Sell	10,183 -1,791	-15%	-$132K	0.11%	158
2015 Q2	$888K	Sell	11,974 -2,027	-14%	-$155K	0.14%	143
2015 Q1	$1.09M	Buy	14,001 +7,228	+107%	+$548K	0.16%	127
2014 Q4	$489K	Sell	6,773 -89	-1%	-$6.18K	0.08%	206
2014 Q3	$425K	Buy	6,862 +225	+3%	+$14.3K	0.07%	213
2014 Q2	$423K	Buy	6,637 +137	+2%	+$8.32K	0.07%	215
2014 Q1	$400K	Hold	6,500	–	–	0.07%	211
2013 Q4	$373K	Hold	6,500	–	–	0.07%	210
2013 Q3	$346K	Hold	6,500	–	–	0.07%	209
2013 Q2	$335K	Buy	+6,500	New	+$321K	0.08%	194

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gerald L. Ray & Associates's MDT Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its Medtronic (MDT) stake by 5.5% in Q3 2017, selling an estimated $15.9K and leaving 3,298 shares worth $256K. The position accounts for 0.03% of the portfolio, ranked #293.

Gerald L. Ray & Associates first reported a position in MDT in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.09M in Q1 2015. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

Gerald L. Ray & Associates held 3,298 shares of Medtronic worth $256K as of Q3 2017.
Gerald L. Ray & Associates sold 191 Medtronic shares in Q3 2017, an estimated $15.9K.
Medtronic made up 0.03% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #293 holding.
Gerald L. Ray & Associates first reported a position in Medtronic in Q2 2013 and has held it in 18 quarters since.
Gerald L. Ray & Associates's Medtronic position peaked at $1.09M in Q1 2015.
1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.